Nadine Vonderlin

Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial

Axel Bauer, Michael Schreinlechner, Nikolay Sappler et al. · The Lancet Respiratory Medicine · 2021 · 101 citations · Full text

Open-label Trial, Hypertension, Cardiovascular Disease +9

Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial

Axel Bauer, Nikolay Sappler, Lukas von Stülpnagel et al. · The Lancet Digital Health · 2022 · 27 citations · Full text

Inhibition of cardiac Kv1.5 and Kv4.3 potassium channels by the class Ia anti-arrhythmic ajmaline: mode of action

Fathima Fischer, Nadine Vonderlin, Edgar Zitron et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2013 · 22 citations

Molecular Pharmacology, Cardiac Muscle, Electrophysiological Evaluation +10

Influence of COVID-19 on general stress and posttraumatic stress symptoms among hospitalized high-risk patients

Ulrich Wesemann, Nino Hadjamu, Gerd Willmund et al. · Psychological Medicine · 2020 · 20 citations · Full text

Psychological Co-morbidities, Psychiatry, Stress +14

Impact of previous left atrial ablation procedures on the mechanism of left atrial flutter: A single‐centre experience

Johannes Siebermair, Simon Kochhäuser, Jana Kupusović et al. · Journal of Cardiovascular Electrophysiology · 2020 · 12 citations · Full text